RT Book, Section
A1 Reynolds, Kerry
A1 Ananthakrishnan, Ashwin
A1 Dougan, Michael
A1 Bardia, Aditya
A2 McKean, Sylvia C.
A2 Ross, John J.
A2 Dressler, Daniel D.
A2 Scheurer, Danielle B.
SR Print(0)
ID 1137618815
T1 Immune-Related Adverse Events (irAEs) in Cancer Patients
T2 Principles and Practice of Hospital Medicine, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843133
LK accessmedicine.mhmedical.com/content.aspx?aid=1137618815
RD 2020/07/04
AB Key  Clinical  Questions  When  should  immune-related  adverse  events  (irAEs)  be  suspected  in  acutely  ill  hospitalized  oncology  patients?  How  do  you  evaluate  an  oncology  patient  who  may  have  an  irAE  related  to  immunotherapy  treatment?  How  do  you  manage  patients  with  irAEs?  What  should  you  consider  when  discharging  a  patient  that  has  been  treated  for  an  irAE?